Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2008
05/15/2008CA2672201A1 Use of myb gene to diagnose and treat t-cell acute lumphoblastic leukemia
05/15/2008CA2669675A1 Combination of er.alpha.+ ligands and histone deacetylase inhibitors for the treatment of cancer
05/15/2008CA2669465A1 Imidazopyrazines as protein kinase inhibitors
05/15/2008CA2669463A1 Method for treating delirium
05/15/2008CA2669450A1 Novel nucleotide analogues as percursor molecules for antivirals
05/15/2008CA2669432A1 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
05/15/2008CA2669266A1 Pyridinone compounds
05/15/2008CA2669187A1 Bicyclic heterocycles, drugs containing said compounds, the use thereof and methods for preparing same
05/15/2008CA2669166A1 Use of an adenosine antagonist
05/15/2008CA2669054A1 18, 21-didesoxymacbecin derivatives for the treatment of cancer
05/15/2008CA2669047A1 Novel compounds and methods for their production
05/15/2008CA2669043A1 Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions
05/15/2008CA2669038A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use
05/15/2008CA2669034A1 Chemical compounds
05/15/2008CA2669021A1 Composition comprising (-)-.delta.9-trans-tetrahydrocannabinol
05/15/2008CA2669019A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
05/15/2008CA2669012A1 Methods and compositions for detecting receptor ligand mimetics
05/15/2008CA2668996A1 1,2,3-triazole derivatives as sigma receptor inhibitors
05/15/2008CA2668994A1 1,2,4-triazole derivatives as sigma receptor inhibitors
05/15/2008CA2668962A1 Azaadamantane derivatives and their uses as nicotinic acetylcholine receptors ligands
05/15/2008CA2668959A1 Indole and benzofuran 2-carboxamide derivatives
05/15/2008CA2668923A1 Use of tri-substituted glycerol compounds for the treatment of radiation injuries
05/15/2008CA2668899A1 (r)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use
05/15/2008CA2668864A1 Pharmaceutical composition comprising a dihydrobenzofuranyl isoindoline and a lipophilic component
05/15/2008CA2668859A1 Pyrimidine derivatives as posh and posh-ap inhibitors
05/15/2008CA2668853A1 Novel triazinedione derivatives as gaba-b receptor modulators
05/15/2008CA2668775A1 Melt-processed imatinib dosage form
05/15/2008CA2668748A1 Polymorph iii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
05/15/2008CA2668731A1 Kinase inhibitors and methods for using the same
05/15/2008CA2668682A1 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives
05/15/2008CA2668679A1 Oxazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
05/15/2008CA2668645A1 Method of treating asthma, allergic rhinitis, and skin disorders
05/15/2008CA2668623A1 Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
05/15/2008CA2668607A1 Nonoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
05/15/2008CA2668556A1 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
05/15/2008CA2668478A1 Carbamate, thiocarbamate or carbamide comprising a biomolecular moiety
05/15/2008CA2668472A1 Improved biological effects of compositions comprising rosmarinic acid
05/15/2008CA2668429A1 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
05/15/2008CA2668414A1 Methods of treating dermatological disorders or conditions
05/15/2008CA2668399A1 Thiazole and oxazole-substituted arylamides
05/15/2008CA2668371A1 Heterocyclyl-substituted anti-hypercholesterolemic compounds
05/15/2008CA2668346A1 Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in the treatment of proliferative diseases
05/15/2008CA2668282A1 Caspase inhibitors based on pyridazinone scaffold
05/15/2008CA2668280A1 5-hydroxymethyl-oxazolidin-2-one derivatives
05/15/2008CA2668190A1 Compounds and compositions as protein kinase inhibitors
05/15/2008CA2668162A1 Use of organic compounds
05/15/2008CA2668134A1 Ascomycin and pimecrolimus having reduced levels of des-methylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
05/15/2008CA2667936A1 Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl]-phenyl}-n-methyl-acetamide
05/15/2008CA2667720A1 Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
05/15/2008CA2667710A1 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors
05/15/2008CA2667682A1 Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
05/15/2008CA2667644A1 Tricyclic compounds as matrix metalloproteinase inhibitors
05/15/2008CA2667565A1 Process for the sulfinylation of a pyrazole derivative
05/15/2008CA2667562A1 Process for the sulfinylation of a pyrazole derivative
05/15/2008CA2667559A1 Process for the sulfinylation of a pyrazole derivative
05/15/2008CA2667488A1 Methods of synthesizing pharmaceutical salts of a factor xa inhibitor
05/15/2008CA2667487A1 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
05/15/2008CA2667477A1 Transdermal delivery of ketoprofen polar derivatives
05/15/2008CA2667348A1 Methods of using saha and bortezomib for treating multiple myeloma
05/15/2008CA2667345A1 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
05/15/2008CA2667259A1 Dosage forms and co-administration of an opioid agonist and an opioid antagonist
05/15/2008CA2667031A1 Hcv ns3 protease inhibitors
05/15/2008CA2666693A1 Reduced-hangover alcoholic beverage comprising turmeric
05/15/2008CA2666306A1 4-1 bb ligand in inflammatory diseases
05/15/2008CA2665778A1 Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases
05/15/2008CA2665073A1 Salt of aliskiren with orotic acid
05/15/2008CA2663925A1 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
05/15/2008CA2641668A1 Desloratadine crystalline forms mixtures having a low level of residual solvents
05/14/2008EP1921136A1 Nucleic acid for treatment or prevention of immunodeficiency virus infection
05/14/2008EP1921133A2 System for processing lipoaspirate cells
05/14/2008EP1921094A2 Method for presenting and removing substances
05/14/2008EP1921091A1 Process for the preparation of esters of the diacerein with hyaluronic acid and pharmaceutical preparations containing them
05/14/2008EP1921086A1 Antitumor agent
05/14/2008EP1921085A1 Therapeutic agent for hypertension
05/14/2008EP1921080A1 Subsitituted 8-piperidinyl-2-pyridinyl-pyrimido(1,2-a)pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido(1,2-a)pyrimidin-6-one derivatives
05/14/2008EP1921079A1 Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
05/14/2008EP1921078A1 Multikinase inhibitor
05/14/2008EP1921077A1 Agent for treating and/or preventing sleep disorder
05/14/2008EP1921074A1 Thiazole derivative
05/14/2008EP1921073A1 1,2,4-Triazole derivatives as sigma receptor inhibitors
05/14/2008EP1921072A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators
05/14/2008EP1921071A1 1,2,3- triazole derivatives as sigma receptor inhibitors
05/14/2008EP1921070A1 Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation
05/14/2008EP1921068A1 Indazole and indole derivatives as anti-inflammatory agents
05/14/2008EP1921067A1 Indole and indazole derivatives as anti-inflammatory agents
05/14/2008EP1921066A1 Pyridylphenol compound and use thereof
05/14/2008EP1921065A1 Phenylpyridone derivative
05/14/2008EP1921064A1 Pharmaceutical composition
05/14/2008EP1921062A2 Amino acid derivatives as HIV aspartyl protease inhibitors
05/14/2008EP1921059A2 Highly nucleated thermoplastic articles
05/14/2008EP1920783A1 Recombinant RSV virus expression systems and vaccines
05/14/2008EP1920775A1 5'Triphosphate oligonucleotide induces anti-viral response
05/14/2008EP1920774A1 Composition containing fucoidan or fucoidan hydrolysate and immunopotentiating material
05/14/2008EP1920773A1 Compositions for inhibition of anglogenesis
05/14/2008EP1920772A1 Prophylactic and/or therapeutic method for rheumatoid arthritis
05/14/2008EP1920771A2 Methods of treating hyperlipidemia
05/14/2008EP1920770A1 Therapeutic agent for inflammatory bowel disease and tnf- alpha production inhibitor
05/14/2008EP1920769A1 Methods and materials for treating conditions associated with metabolic disorders
05/14/2008EP1920767A1 Melt-processed imatinib dosage form
05/14/2008EP1920764A1 Fluprostenol isopropyl ester for use in the treatment of glaucoma and ocular hypertension
1 ... 3264 3265 3266 3267 3268 3269 3270 3271 3272 3273 3274 3275 3276 3277 3278 3279 3280 3281 3282 3283 3284 ... 7860